Acadian Asset Management LLC Purchases 166,776 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Acadian Asset Management LLC lifted its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 32.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 675,207 shares of the company’s stock after purchasing an additional 166,776 shares during the period. Acadian Asset Management LLC owned about 1.67% of Phibro Animal Health worth $8,726,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Illinois Municipal Retirement Fund lifted its stake in shares of Phibro Animal Health by 7.2% in the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after acquiring an additional 765 shares during the period. BNP Paribas Financial Markets grew its holdings in Phibro Animal Health by 290.2% during the 4th quarter. BNP Paribas Financial Markets now owns 73,287 shares of the company’s stock worth $849,000 after acquiring an additional 54,506 shares during the period. China Universal Asset Management Co. Ltd. lifted its stake in shares of Phibro Animal Health by 358.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company’s stock valued at $27,000 after purchasing an additional 1,843 shares during the period. Wellington Management Group LLP boosted its position in shares of Phibro Animal Health by 165.9% during the 4th quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after purchasing an additional 102,793 shares in the last quarter. Finally, Louisiana State Employees Retirement System bought a new stake in Phibro Animal Health in the fourth quarter worth approximately $118,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Stock Up 1.3 %

PAHC traded up $0.24 during midday trading on Monday, reaching $18.88. 41,468 shares of the company were exchanged, compared to its average volume of 141,567. The company has a market cap of $764.64 million, a price-to-earnings ratio of 58.41, a price-to-earnings-growth ratio of 4.89 and a beta of 0.57. Phibro Animal Health Co. has a one year low of $9.40 and a one year high of $19.55. The company’s fifty day moving average price is $17.69 and its 200 day moving average price is $14.48. The company has a debt-to-equity ratio of 1.69, a quick ratio of 1.67 and a current ratio of 3.16.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.02. The business had revenue of $263.20 million during the quarter, compared to the consensus estimate of $251.82 million. Phibro Animal Health had a return on equity of 17.11% and a net margin of 1.32%. As a group, analysts expect that Phibro Animal Health Co. will post 1.13 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Investors of record on Wednesday, June 5th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.54%. The ex-dividend date was Wednesday, June 5th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 150.00%.

Analysts Set New Price Targets

Several brokerages have recently commented on PAHC. Barclays raised their price objective on shares of Phibro Animal Health from $10.00 to $13.00 and gave the stock an “underweight” rating in a research report on Friday, May 10th. StockNews.com raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Tuesday, April 9th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Phibro Animal Health currently has a consensus rating of “Hold” and an average target price of $14.75.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.